These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 130761)

  • 21. [Antibiotic resistance pattern of 24, 526 strains of Vibrio cholerae O1 isolated in Mexico from 1991 to 1993].
    Giono-Cerezo S; Zárate A; Gutiérrez L; Valdespino JL
    Rev Latinoam Microbiol; 1994; 36(4):257-62. PubMed ID: 7701135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibacterial, antisecretory and antihemorrhagic activity of Azadirachta indica used to treat cholera and diarrhea in India.
    Thakurta P; Bhowmik P; Mukherjee S; Hajra TK; Patra A; Bag PK
    J Ethnopharmacol; 2007 May; 111(3):607-12. PubMed ID: 17314018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Bacteriological aspects of cholera in Benin (epidemic of 1991)].
    Anagonou SY; Josse R; Foundohou J; Helynck B; Massougbodji A; Sadeler BC
    Bull Soc Pathol Exot; 1993; 86(5):333-5. PubMed ID: 8124099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Resistance to antibiotics of Vibrio cholerae and its possible prognostic significance].
    Ved'mina EA; Givental' NI; Sobolev VR; Ogneva NS; Voronin IuS
    Antibiotiki; 1984 Apr; 29(4):260-3. PubMed ID: 6742803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Is Vibrio cholerae serotype 0139 a potential cause of a new pandemic?].
    Dalsgaard DA; Larsen JL
    Ugeskr Laeger; 1995 Jan; 157(3):280-3. PubMed ID: 7846774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Possibilities of immunization against cholera and related enterotoxic enteropathies.
    Finkelstein RA
    Dev Biol Stand; 1976; 33():102-7. PubMed ID: 955264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endemic cholera in Delhi, 1995: analysis of data from a sentinel centre.
    Singh J; Sachdeva V; Bhatia R; Bora D; Jain DC; Sokhey J
    J Diarrhoeal Dis Res; 1998 Jun; 16(2):66-73. PubMed ID: 9805411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Breast milk reduces the risk of illness in children of mothers with cholera: observations from an epidemic of cholera in Guinea-Bissau.
    Qureshi K; Mølbak K; Sandström A; Kofoed PE; Rodrigues A; Dias F; Aaby P; Svennerholm AM
    Pediatr Infect Dis J; 2006 Dec; 25(12):1163-6. PubMed ID: 17133163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Value of vibriocidal antibody research in endemic areas of Vibrio cholerae 0:1].
    Bendib A; Bougoudogo F; Messast M; Rezkallah D; Hamchi L; Bellouche Y; Aidoud NS; Keddouri A; Fournier JM; Dodin A
    Bull Soc Pathol Exot; 1994; 87(1):33-7. PubMed ID: 8003902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Features of Vibrio cholerae 0:1 El Tor, Inaba serotype, isolated during the cholera epidemic in Cartagena (Colombia)].
    Salim Máttar V
    Enferm Infecc Microbiol Clin; 1992 Nov; 10(9):525-30. PubMed ID: 1489792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vibriocidal titre in cholera cases and contacts: its value in assessing endemicity of or susceptibility to cholera.
    Khan MU; Barua DK; Begum T; Shahidullah M
    Trop Geogr Med; 1987 Jul; 39(3):271-5. PubMed ID: 3433343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Vibrio cholerae strains resistant to vibriostatic factor 0/129 isolated from a patient with cholera in Poland].
    Stypułkowska-Misiurewicz H; Gardocka H; Sieczka Z
    Med Dosw Mikrobiol; 1994; 46(4):313-21. PubMed ID: 7603133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experimental immunisation and protection of guinea pigs with Vibrio cholerae toxoid and mucinases, neuraminidase and proteinase.
    Stewart-Tull DE; Lucas C; Bleakley CR
    Vaccine; 2004 Jun; 22(17-18):2137-45. PubMed ID: 15149770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Characterization of a multiresistant strain of Vibrio cholerae O1, isolated from a case of cholera in Chile].
    Castillo L; Ulloa MT; Martínez MA; Silva W; Seoane M; Maldonado A; Castillo P
    Rev Med Chil; 1994 Sep; 122(9):986-92. PubMed ID: 7597345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The resistance of cholera vibrios to antibiotics].
    Podosinnikova LS; Domaradskiĭ IV; Ermol'eva ZV; Ryzhko IV
    Antibiotiki; 1974 Mar; 19(3):219-23. PubMed ID: 4499703
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of some methods used for the testing of the effect of disinfectants.
    István V
    Acta Pharm Hung; 1980 May; 50(3):102-12. PubMed ID: 6791460
    [No Abstract]   [Full Text] [Related]  

  • 37. Efficacy of a live oral cholera vaccine in human volunteers.
    Woodward WE; Gilman RH; Hornick RB; Libonati JP; Cash RA
    Dev Biol Stand; 1976; 33():108-12. PubMed ID: 782960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Class 1 integrons and SXT elements conferring multidrug resistance in Vibrio cholerae O1 strains associated with a recent large cholera outbreak in Orissa, Eastern India.
    Jain M; Kumar P; Goel AK; Kamboj DV; Singh L
    Int J Antimicrob Agents; 2008 Nov; 32(5):459-60. PubMed ID: 18706789
    [No Abstract]   [Full Text] [Related]  

  • 39. [Possibility of quickly determining the sensitivity of cholera vibrio to antibiotics using erythrocytic diagnosticum].
    Roshchin VV; Suleĭmenov BM; Semiotrochev VL
    Lab Delo; 1971; 8():501-2. PubMed ID: 4114051
    [No Abstract]   [Full Text] [Related]  

  • 40. Cholera vaccine will reduce antibiotic use.
    Okeke IN
    Science; 2009 Aug; 325(5941):674. PubMed ID: 19661401
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.